Therefore, more studies are needed with SGLT2 inhibitors in T1D patients, to fully evaluate their therapeutic potential in this specific population
This multifaceted approach not only leads to significant weight loss but also helps manage conditions like type 2 diabetes, making it a powerful tool for improving both physical and metabolic health
Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G
Mounjaro (tirzepatide) is an injectable prescription medication developed by Eli Lilly that was first approved by the U.S
Ozempic podra causar efectos secundarios graves, entre ellos: Los efectos secundarios ms comunes de Ozempic podran incluir nuseas, vmitos, diarrea, dolor de estmago (abdominal) y estreimiento